LOGGI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.689
AS - Asia 2.849
EU - Europa 2.090
AF - Africa 182
SA - Sud America 161
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 8.973
Nazione #
US - Stati Uniti d'America 3.642
SG - Singapore 842
CN - Cina 709
VN - Vietnam 679
GB - Regno Unito 529
SE - Svezia 351
DE - Germania 266
IT - Italia 265
HK - Hong Kong 208
FR - Francia 138
IN - India 131
BR - Brasile 118
UA - Ucraina 102
IE - Irlanda 88
RU - Federazione Russa 87
NL - Olanda 62
KR - Corea 54
ZA - Sudafrica 53
TG - Togo 51
JP - Giappone 45
BE - Belgio 40
FI - Finlandia 36
EE - Estonia 34
JO - Giordania 32
CI - Costa d'Avorio 31
CA - Canada 29
PH - Filippine 23
CH - Svizzera 22
SC - Seychelles 21
BD - Bangladesh 20
TH - Thailandia 19
AR - Argentina 18
GR - Grecia 15
BG - Bulgaria 14
TW - Taiwan 14
IR - Iran 13
MX - Messico 12
IQ - Iraq 11
EC - Ecuador 8
PL - Polonia 8
AT - Austria 7
ID - Indonesia 7
TR - Turchia 7
ES - Italia 6
LB - Libano 6
NG - Nigeria 6
PK - Pakistan 6
SA - Arabia Saudita 6
CL - Cile 4
RO - Romania 4
VE - Venezuela 4
CO - Colombia 3
DK - Danimarca 3
ET - Etiopia 3
MY - Malesia 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
TN - Tunisia 3
CR - Costa Rica 2
DZ - Algeria 2
PY - Paraguay 2
QA - Qatar 2
SN - Senegal 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
CG - Congo 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GN - Guinea 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LY - Libia 1
MA - Marocco 1
ML - Mali 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UY - Uruguay 1
YT - Mayotte 1
Totale 8.973
Città #
Singapore 614
Southend 459
Ashburn 371
Fairfield 366
Chandler 341
San Jose 219
Hong Kong 198
Woodbridge 180
Ann Arbor 175
Dong Ket 158
Houston 157
Santa Clara 152
Seattle 150
Wilmington 148
Ho Chi Minh City 143
Cambridge 134
Hefei 134
Hanoi 115
Princeton 111
Dublin 88
Beijing 86
Boardman 76
Jacksonville 63
Dallas 52
Lauterbourg 51
Lomé 51
Nanjing 51
Seoul 47
Westminster 47
Padova 44
Council Bluffs 42
Brussels 39
Los Angeles 37
Tokyo 37
Bologna 33
São Paulo 33
Amman 32
Jinan 32
Abidjan 31
Buffalo 28
Berlin 26
Changsha 25
Da Nang 24
San Diego 24
Helsinki 23
Shenyang 23
Frankfurt am Main 22
Haiphong 22
Turin 22
Milan 21
Munich 19
New York 18
Redondo Beach 18
Hebei 17
Nanchang 17
Rome 16
Bern 15
Bremen 15
Saint Petersburg 15
Bengaluru 14
Bangkok 13
Mülheim 13
Sofia 13
Zhengzhou 13
San Francisco 12
Florence 11
Guangzhou 11
Johannesburg 11
Mahé 11
Tianjin 11
Toronto 11
Amsterdam 10
Des Moines 10
London 10
Turku 10
Hải Dương 9
Ningbo 9
Orem 9
Redmond 9
Dearborn 8
Kunming 8
Phoenix 8
Taizhou 8
Washington 8
Xi'an 8
Yubileyny 8
Biên Hòa 7
Dolo 7
Falkenstein 7
Shanghai 7
Abeokuta 6
Bình Phước 6
Haikou 6
Jiaxing 6
Lanzhou 6
Medford 6
Montreal 6
Paris 6
Quezon City 6
Redwood City 6
Totale 6.071
Nome #
Adaptive response in Hepatitis B virus infection 254
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. 237
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 229
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 211
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 207
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 207
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 204
Vitamins in the treatment of chronic viral hepatitis. 201
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 199
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma. 197
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen. 195
Alcoholic liver disease: pathophisiological aspects and risk factors. A review. 192
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients. 192
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. 189
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 184
Chronic hepatitis B: Are we close to a cure? 183
Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis 183
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. 181
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 180
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 177
Hepatitis B virus and immune response. 174
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report 174
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B 173
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. 173
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 171
Serum SCCA-IgM as a predictor of hepatocellular carcinoma in patients with liver cirrhosis 168
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 168
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. 168
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. 167
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C. 166
Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" 165
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis. 163
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. 157
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature 155
Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV. 153
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 152
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. 152
Ketoprofen, peginterferon-alpha2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study. 150
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 147
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C. 145
SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses 145
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. 144
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients 139
Virological Treatment Monitoring for Chronic Hepatitis B 134
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS). 134
Proteomics of immune cells from liver tumors reveals immunotherapy targets 129
The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection 125
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis. 120
Host ethnicity and genotype shape the hepatitis B virus-specific T-cell repertoire 117
METABOLIC EFFECTS OF ANTI-HCV DIRECT ACTING ANTIVIRALS (DAA): A RETROSPECTIVE STUDY 114
Sustained and focused HBV-nucleocapsid-specific T cell immunity in liver transplant recipients compared to individuals with chronic and self-limited HBV infection. 111
null 98
Infections and organ transplantation: new challenges for prevention and treatment--a colloquium. 98
SPONTANEOUS MOBILIZATIONOF BONE MARROW-DERIVED HEMATOPOIETIC AND ENDOTHELAIL PROGENITOR CELLS AFTER ORTHOTOPIC LIVER TRANSPALNTATION (OLT). 97
null 92
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era 23
Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome 13
Totale 9.076
Categoria #
all - tutte 23.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021212 0 0 0 0 0 0 0 0 0 0 0 212
2021/20221.108 76 32 93 118 83 58 18 61 46 107 229 187
2022/20231.165 140 204 65 164 62 99 28 47 192 32 84 48
2023/2024257 17 55 21 34 24 32 11 29 5 15 3 11
2024/20251.135 32 182 63 104 198 47 55 22 25 69 38 300
2025/20262.779 211 248 274 222 368 143 256 131 553 200 88 85
Totale 9.076